Browse Newsroom

Prof. Dr. Howard Maibach joins InsuLife as Scientific Advisor

June 15, 2021

InsuLife is pleased to announce the appointment of Dr. Howard Maibach as our Scientific Advisor. Dr. Maibach is considered one of the prominent dermatologists in the world and is co-author of more than 1400 scientific publications. He is a Professor in dermatology at the University of California, San Francisco.

Dr. Maibach earned his medical degree from Tulane University School of Medicine. He completed a residency as well as a fellowship in dermatology at the Hospital of the University of Pennsylvania.

Dr. Maibach has served on the editorial boards of more than 30 scientific journals. He is a member of 19 professional societies, including the American Academy of Dermatology, San Francisco Dermatological Society and International Commission on Occupational Health.

Learn more about Dr. Maibach here:

Subscribe for InsuLife News Updates
Sign up to receive the latest InsuLife news, updates and investing information delivered right to your inbox.
Newsletter Form (#1)
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved